The results showed increased PHF20L1 expression in ovarian cancer tissue compared with healthy ovaries; overexpression showed a negative trend with patient progression-free survival (PFS) and overall survival (OS). The gene discussed is PHF20L1; the disease is ovarian carcinoma.